<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03701893</url>
  </required_header>
  <id_info>
    <org_study_id>FEC/18.01</org_study_id>
    <nct_id>NCT03701893</nct_id>
  </id_info>
  <brief_title>Evaluate the Use of a New Probiotic Strain in Couples With Fertility Problems and Dysbiosis.</brief_title>
  <acronym>PROFEC</acronym>
  <official_title>Evaluate the Effect of the Strain Lactobacillus PS11610 on the Microbiota of the Female and Male Genital Tract in Couples With Fertility Problems and Dysbiosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProbiSearch SL</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ProbiSearch SL</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot study to evaluate the effect of the strain Lactobacillus PS11610 on the microbiota of&#xD;
      the female and male genital tract in couples with fertility problems. Couples who have&#xD;
      started treatment for artificial insemination or who are on the waiting list for an invitro&#xD;
      fertilization treatment will be invited to participate. The estimated duration of the study&#xD;
      will be 7 and a half months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pilot study to evaluate the effect of the strain Lactobacillus PS11610 on the microbiota of&#xD;
      the female and male genital tract in couples with fertility problems. Couples who have&#xD;
      started treatment for artificial insemination or who are on the waiting list for an invitro&#xD;
      fertilization treatment will be invited to participate. The estimated duration of the study&#xD;
      will be 7 and a half months.&#xD;
&#xD;
      Four visits are included in the study period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 22, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open label intervention study.</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Counts of microorganisms presents in cultured samples of genital tracts obtained from infertility couples.</measure>
    <time_frame>7 months and a half</time_frame>
    <description>The microbial composition obtained by culture of genital tracts samples from couples with infertility</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Infertility</condition>
  <condition>Vaginal Flora Imbalance</condition>
  <condition>Genital Disorder</condition>
  <arm_group>
    <arm_group_label>Lactobacillus PS11610</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus PS11610 for couples with genital dysbiosis and infertility. Each dose contains 1*10E9 colony forming unit (CFU) of Lactobacillus PS11610.Two daily doses for her and one daily dose for him until pregnancy or end of study period (6 months).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus PS11610</intervention_name>
    <description>7 months and a half intervention study. A 6 months intervention period preceded by a period of sampling and analysis of vaginal, seminal and gland swabs of 6 weeks. During the 6 months of intervention the men participants will intake one capsule that contains 1*10E9 colony forming unit (CFU) of Lactobacillus PS11610 and the women participating will intake two capsules of the same product (each 12 hours). If the couple stay pregnant during the intervention the man will end the product intake and the woman will reduce the dose to one capsule with 1*10E9 CFU of Lactobacillus PS11610 per day during 12 additional weeks.</description>
    <arm_group_label>Lactobacillus PS11610</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Couples with ages between 20 and 40&#xD;
&#xD;
          -  Couples under an assisted reproduction treatment: Artificial Insemination or In vitro&#xD;
             Fertilization.&#xD;
&#xD;
          -  Signature of informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anovulation&#xD;
&#xD;
          -  Hyperprolactinemia&#xD;
&#xD;
          -  Hypogonadotropic hypergonadism&#xD;
&#xD;
          -  Hypergonadotropic Hypergonadism&#xD;
&#xD;
          -  Hyperandrogenisms&#xD;
&#xD;
          -  Polycystic ovary syndrome&#xD;
&#xD;
          -  Endometriosis&#xD;
&#xD;
          -  Pelvic adhesions&#xD;
&#xD;
          -  Myomas, polyps and / or uterine synechia&#xD;
&#xD;
          -  Diagnosis of tubal factor (hydrosalpinx, tubal obstructions)&#xD;
&#xD;
          -  Low ovarian reserve&#xD;
&#xD;
          -  Azoospermia&#xD;
&#xD;
          -  Sperm motility (A + B) &lt;25%&#xD;
&#xD;
          -  Sperm morphology ≤2%&#xD;
&#xD;
          -  With chronic diseases that cause intestinal malabsorption&#xD;
&#xD;
          -  With known congenital or acquired immunodeficiency.&#xD;
&#xD;
          -  Obesity (IMC ≥ 30)&#xD;
&#xD;
          -  Current history or diagnosis of alcohol, tobacco and drug abuse&#xD;
&#xD;
          -  Uncertainty about the willingness or ability of the participants to comply with the&#xD;
             requirements of the protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susana Manzano, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>ProbiSearch SL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 8, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2018</study_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

